Lexaria Bioscience Corp (LEXX) Company Profile & Statistics

Lexaria Bioscience Corp
LEXX
(Nasdaq - US)
N/A
3.39
+0.26 (+8.31%)
in:usd•As of: May 06, 2024 15:59 UTC -4
Open
3.37
High
3.40
Low
3.25

About Lexaria Bioscience Corp

CEO

Christopher Bunka

Headquarters

100 - 740 mccurdy road

kelowna, a1 v1x 2p7, canada

Auditor

MaloneBailey, LLP

Employees

Share Holders

Website

www.lexariabioscience.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.

Lexaria Bioscience Corp Statistics

Valuation Measures

Market Capitalization ²	43.70M
Enterprise Value	38.99M
Enterprise Value/EBITDA (ttm)	-7.53
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.30
Price to Sales (ttm)	118.28
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	95.78%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-2968.65%
Return on Equity (ttm)	-133.97%
Return on Invested Capital (ttm)	-151.34%
Return on Assets (ttm)	-118.89%

Income Statement

Revenue (ttm)	404.80K
Revenue Per Share (ttm)	0.03
Gross Profit (ttm)	387.20K
EBITDA (ttm)³	-5.18M
Net Income Avi to Common (ttm)	-5.44M
Diluted EPS (ttm)	-0.68

Share Statistics

Beta (5Y Monthly)	0.99
52-Week Change	230.73%
S&P500 52-Week Change	27.73%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	12.89M
Dividend Yield	0.00%
Float ⁴	11.90M
% Held by Insiders	7.61%
% Held by Institutions	13.06%

Balance Sheet

Total Cash (mrq)	4.79M
Total Cash Per Share (mrq)	0.37
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	66.29%
Quick Ratio (mrq)	66.29%
Book Value Per Share (mrq)	0.50

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.17
Free Cash Flow (ytd)	-1.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Lexaria Bioscience Corp

Trade With A Regulated Broker